Articles at Genital-Herpes-Facts
|
Genital Herpes Article
Genital Herpes - How Prevalent Is It And What Should You Do?
from:Genital herpes is a topic not readily discussed in the course of
normal conversation however, if you're aged 25 and over, and are
sexually active with multiple partners then it would be wise to
be tested for genital herpes.
A recent study in Australia ( May 2006 ) revealed at least one
in eight people people in that country have genital herpes. If
that sounds alarming then it should be. A first nation-wide
study also found herpes was most prevalent in people aged 35 to
44 and city folk were more likely to be carrying the virus than
their "country cousins."
So what to do? Being a little less promiscuous could be the
answer but this would only be a superficial fix. The problem
lies in the fact that at least 80 per cent of people who have
genital herpes don't know they have it. And it's fair to say
those who contract the virus do so innocently. Affected people
who pass it on and are a unaware they have it, don't experience
the symptons. The obvious answer once again is to get tested
especially if you've had multiple partners.
Why are people reluctant to be tested? Is there are kind of aura
of shame with knowing you have genital herpes? Medical experts
will tell you don't be embarrassed; the sooner you have the
condition treated the better. Makes sense. So why don't people
get tested or why do they delay the process? Maybe more
educational programs should be put in place but from where I
sit, I think the proper authorities have performed a good job in
making the community aware of their responsibilities in this
area.
The news is not so good for women. Twice as many women are
likely to contract genital herpes than men simply because of
their physiological make up. This doesn't suggest men have less
responsibility in getting tested than women. It's a two-way
street.
The study found the prevalence of herpes varies from country to
country with genital herpes more prevalent in some while oral
herpes was confirmed at a higher rate in others.
Get over any short time embarrassment you may experience
initially and do the sensible thing; not just if you have
multiple partners: if it doesn't feel right, consult your
doctor. Sound advice for mine.
About the author:
NoneDean Caporella is a professional Journalist and Sportscaster
who takes an interest in a wide range of subjects. "Infection
and disease can be a morbid subject to touch on," Dean says "but
the truth is it's part of human society and we need to stay
informed." Get the news, views and reviews at
www.yourinfectionsite.com
Other Genital Herpes related Articles
The Incredible Mystical Formidable Herpes Virus
Cold Sores You Can Prevent Outbreaks
Sexually Addicted 10 Important Questions To Ask
Health Complications With Genital Herpes
Whos Got Herpes
Do you want to contribute to our site : submit your articles HERE
Genital Herpes News
Antigenics Presents Positive, Top Line Data From Phase I Herpes Clinical Trial
Antigenics (NASDAQ: AGEN) announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2 (HSV-2), the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells. "I believe these data represent the first finding of their ...
Read more...Antigenics announces positive result for AG-707 to treat genital herpes
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Read more...Antigenics posts positive herpes drug study data
Antigenics reported positive data Tuesday from an early stage clinical therapy trial to treat herpes simplex virus-2, the virus that causes genital herpes.
Read more...Antigenics shares up on progress with herpes drug
NEW YORK (MarketWatch) - Antigenics Inc. shares leaped 20% in Tuesday trading. The Salt Lake City biotechnology company, which is focused on treatments for cancer and infectious diseases, reported progress in a Phase I trial of AG-707, a drug under development to treat herpes simplex virus-2, the virus that causes genital herpes. "Being able to impact and possibly decrease the spread of genital ...
Read more...Collaboration Solves Structure Of Herpes Virus Protein, Provides New Drug Directions
The mechanism by which a herpes virus invades cells has remained a mystery to scientists, but now research from Tufts University and the University of Pennsylvania reveals the unusual structure of a key member of the protein complex that allows a herpes virus to invade cells.The new map details an essential piece of the herpes virus cell-entry machinery, providing scientists with a new target ...
Read more...